Stay updated on ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.

Latest updates to the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record for the sunitinib and/or nivolumab study in advanced soft tissue and bone sarcomas is displayed, with details on study design, treatment arms, eligibility, locations, and outcome measures.SummaryDifference100%

- Check17 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice about updates to terminology for artificial intelligence appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision marker changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check52 days agoChange DetectedRemoved the 403 Forbidden error content from the study record page, and the page now renders with the standard ClinicalTrials.gov header and footer instead of the error screen.SummaryDifference0.5%

Stay in the know with updates to ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.